Featured Inquiries and Replies
Ask an Expert
cHL | R/R
Lymphoma Specialist
Hematologist, Oncologist
Would you agree with my treatment selection for my patient with advanced-stage EBV-associated cHL?
Read Response
GI | Age 74 | R/R
GI Cancer Specialist
Hematologist, Oncologist
What treatment would you recommend for a 74 yo patient with well-differentiated pancreatic neuroendocrine neoplasm who has progressed on cape/tem w/new liver lesion and enlargement of the pancreatic mass?
Read Response
MPN | Age 43 | R/R
Myeloproliferative Neoplasms Specialist
Hematologist, Oncologist
Would you discontinue Nilotinib for CML after 3 years of treatment if patient achieved MR4 only for > 2years (not MR 4.5) with prior imitanib failure?
Read Response
Multiple Myeloma
Multiple Myeloma Specialist
Hematologist, Oncologist
What regimen of VRD you choose in transplant eligible patients?
Read Response
MM | Age 72 | New Dx
MM Expert
Hematologist, Oncologist
What treatment would you recommend for an elderly frail patient with t(4;14) myeloma?
Read Response
CLL | Age 80 | R/R
CLL Expert
Hematologist, Oncologist
What would be the next line of treatment for this patient who is coming off of a trial for CLL?
Read Response
Ask an Expert
Disclaimer: These are examples of platform discussions and should be viewed for educational purposes only.